Our SafeMedWaste products meet all of the applicable requirements of the DEA and EPA. Our goal is to combat the opioid epidemic by attacking the problem at its source. Okra Medical is dedicated to impacting the social problem of addiction, both in healthcare facilities and in communities nationwide by providing an easily implemented, safe, and cost-effective method to destroy highly addictive substances.

 

HPLC/MS and/or HPLC/DAD results are available for each substance upon request. Testing was completed by an independent lab that is FDA- Registered, DEA-Licensed, GMP/GLP-Compliant, and REACH/RoHS Compliant.

 

HPLC-MS results validating that SafeMedWaste is effective on each controlled substance individually and as a mixture.

 

BETA test results also available show that SafeMedWaste is effective in real-world scenarios. 

 

Testing performed on SafeMedWaste to date: TCLP ( Toxicity characteristics and leach protocol), Off-Gassing, Ignitability/Flamability, Corrosivity, and transportation.  

 
* Certain controlled substances that are also regulated by the EPA are pending EPA concurrence.

3538 Meeks Farm Rd
Johns Island, SC 29455

 

 833-657-2633
 info@okramedical.com

  • White LinkedIn Icon
Okra Medical
 2019 InnoVision Finalist
© 2020 Okra Medical, Inc.  All rights reserved in all countries. 
SAFEMEDWASTE™ and Okra Medical™ are trademarks of
Okra Medical, Inc. 
Okra Medical is DEA Registered.